Chang, Ke;
Chen, Hua;
Chen, Yaxin;
Feng, Xiaochun;
Gao, Jian;
Gao, Xiuan;
Hu, Ziteng;
Li, Jijun;
Li, Min;
Li, Xinmin;
Liang, Ning;
Ming, Xi;
Qin, Yanhong;
Wang, Lining;
Wang, Xuefeng;
Wu, Liqun;
Yan, Lijiao;
Yang, Yijiu;
Zhang, Baoqing;
Zhang, Xuefei;
Zhang, Yujing.
Children are highly susceptible to influenza and are at high risk for severe cases. Chinese patent medicine (CPM) offers advantages in treating pediatric influenza, but the issue of its improper use is increasingly prevalent in clinical practice. To address this, we adopted a dual leadership approach inv...
Wu, Lei;
Chen, Yaolong;
Ma, Yanfang;
Yang, Zifeng;
Yang, Nan;
Denga, Wenze;
Chen, Yuanbin;
Sun, Yuanyuan;
Li, Yimin;
Lin, Lin.
Influenza is a major public health problem worldwide. Mutations and resistance development make the use of antiviral therapy challenging. Chinese patent medicines are often used to treat influenza in China and well tolerable. However, the misuse of Chinese patent medicines is common. We therefore aimed t...
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...
The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...
This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....
